Literature DB >> 31316300

Erratum to "Epac1 Restores Normal Insulin Signaling through a Reduction in Inflammatory Cytokines".

Elizabeth Curtiss1, Youde Jiang1, Li Liu1, Claire Hawthorne1, Jessica Zhang1, Jena J Steinle1,2.   

Abstract

[This corrects the article DOI: 10.1155/2018/3809092.].

Entities:  

Year:  2019        PMID: 31316300      PMCID: PMC6604461          DOI: 10.1155/2019/4524179

Source DB:  PubMed          Journal:  Mediators Inflamm        ISSN: 0962-9351            Impact factor:   4.711


In the article titled “Epac1 Restores Normal Insulin Signaling through a Reduction in Inflammatory Cytokines” [1], it was found that the western blots in Figures 5(b) and 5(c) were duplicated. This error happened during the production process. The corrected figure is shown below.
Figure 1

(a) Western blotting for the ratio of IL-1β siRNA to β-actin in REC grown in normal glucose (NG) and high glucose (HG). Some REC grown in HG were transfected with IL-1β siRNA or scrambled siRNA (sc). (b–d) Western blotting for the ratio of phosphorylated insulin receptor on tyrosine 1150/1151 (p-IR), IRS-1Ser307 (p-IRS-1), and Akt (p-Akt) to total protein. (e) ELISA results for cleaved caspase 3 levels. ∗P < 0.05 versus NG, #P < 0.05 versus HG. N = 4 or 5 for all groups. Data are mean ± SEM.

  1 in total

1.  Epac1 Restores Normal Insulin Signaling through a Reduction in Inflammatory Cytokines.

Authors:  Elizabeth Curtiss; Youde Jiang; Li Liu; Claire Hawthorne; Jessica Zhang; Jena J Steinle
Journal:  Mediators Inflamm       Date:  2018-07-19       Impact factor: 4.711

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.